SLGL
Sol Gel Technologies LtdNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$248.26M
P/E Ratio
—
EPS
$-2.19
Beta
1.27
52W High
$97.97
52W Low
$4.11
50-Day MA
$77.96
200-Day MA
$43.51
Dividend Yield
—
Profit Margin
-31.60%
Forward P/E
9.34
PEG Ratio
—
About Sol Gel Technologies Ltd
Sol-Gel Technologies Ltd., a specialty clinical-stage pharmaceutical company, is focused on developing and commercializing topical dermatological pharmaceuticals based on its Israel-patented microencapsulation delivery system. The company is headquartered in Ness Ziona, Israel.
Fundamentals
| Revenue (TTM) | $19.39M |
| Gross Profit (TTM) | $-3.42M |
| EBITDA | $-7.48M |
| Operating Margin | -497.90% |
| Return on Equity | -23.70% |
| Return on Assets | -14.40% |
| Revenue/Share (TTM) | $6.96 |
| Book Value | $8.19 |
| Price-to-Book | 10.59 |
| Price-to-Sales (TTM) | 12.80 |
| EV/Revenue | 11.27 |
| EV/EBITDA | 0.23 |
| Quarterly Earnings Growth (YoY) | 487.60% |
| Quarterly Revenue Growth (YoY) | 150.40% |
| Shares Outstanding | $3.25M |
| Float | 871,030 |
| % Insiders | 53.98% |
| % Institutions | 35.30% |
Historical Volatility
HV 10-Day
101.80%
HV 20-Day
131.38%
HV 30-Day
126.86%
HV 60-Day
111.54%
HV Rank
—
Volatility is currently contracting
Data last updated: 4/15/2026